Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion.

Histopathology

Department of Pathology, Marie Lannelongue Surgical Centre, Le Plessis-Robinson, France; INSERM UMR 999, LabEx LERMIT, Marie Lannelongue Surgical Centre, Le Plessis-Robinson, France; School of Medicine, University Paris-Sud, Kremlin-Bicêtre, France.

Published: August 2014

Aims: Angiomatoid fibrous histiocytoma (AFH) is a rare neoplastic disease usually occurring in the dermis or subcutis of the extremities of young adults or children. Although sporadic cases in deep soft tissue and visceral organs have been reported, we present here the first description of AFH developing in a large artery.

Methods And Results: Paraffin sections of the surgical specimen were stained with haematoxylin and eosin, and immunohistochemistry was performed (CKAE1/AE3, EMA, CD34, p63, CD38, smooth muscle actin, and desmin). In addition, FISH and RT-PCR were applied in order to check for EWRS rearrangement. The histomorphological features, and FISH analysis revealing rearrangement of EWSR, indicated the definitive diagnosis of AFH. RT-PCR confirmed EWSR rearrangement, and detected an EWSR1-ATF1 fusion transcript.

Conclusions: A thoracic location of AFH has not been reported until very recently, and shares a differential diagnosis with diverse neoplasms, including spindle cell carcinoma and low-grade sarcoma. We describe the first reported case of thoracic AFH arising in a large vessel, and highlight distinctive histological and molecular features.

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12429DOI Listing

Publication Analysis

Top Keywords

angiomatoid fibrous
8
fibrous histiocytoma
8
afh
5
histiocytoma pulmonary
4
pulmonary artery
4
artery multidisciplinary
4
multidisciplinary discussion
4
discussion aims
4
aims angiomatoid
4
histiocytoma afh
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!